Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions
Remarks:
see deviations; impact discussed in conclusion

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1994

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
1981
Deviations:
yes
Remarks:
no positive control was provided; too few animals (10 vs. 20 in case of no sensitisation classification)
GLP compliance:
no
Remarks:
audit performed
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
According to REACH Regulation, no in vivo assay should be performed when it is possible to conclude with the available studies or with in vitro/ in chemico methods. A Magnusson and Kligman assay has been carried out in 1981, which is robust enough to support a non classification of the test item. Therefore, no further testing has been testing, and that's why no LLNA assay has been performed.

Test material

Constituent 1
Chemical structure
Reference substance name:
Dodecyl 5-oxo-L-prolinate
EC Number:
245-224-1
EC Name:
Dodecyl 5-oxo-L-prolinate
Cas Number:
22794-26-9
Molecular formula:
C17H31NO3
IUPAC Name:
dodecyl 5-oxo-L-prolinate

In vivo test system

Test animals

Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: LEBEAU GAMBAIS
- Microbiological status of animals, when known: not specified
- Age at study initiation: not specified
- Weight at study initiation: 200 to 250 g
- Housing: 5 per cage
- Water (e.g. ad libitum): yes
- Acclimation period: at least 5 days before treatment
- Indication of any skin lesions: no skin lesion

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 22 °C
- Humidity (%): 50 to 80 %
- Air changes (per hr): 3000 m3/hour
- Photoperiod (hrs dark / hrs light): 12 hours

Study design: in vivo (non-LLNA)

Induction
Route:
intradermal and epicutaneous
Vehicle:
water
Concentration / amount:
0.25 mL of product at 5% in distilled water for intradermal injection
0.5 mL of undiluted product for dermal induction
Day(s)/duration:
J0 to J8
Adequacy of induction:
not specified
Challenge
Route:
epicutaneous, semiocclusive
Vehicle:
water
Concentration / amount:
0.25ml of product
Day(s)/duration:
J25 (24 hours of exposure)
Adequacy of challenge:
not specified
No. of animals per dose:
10 per condition
Details on study design:
A preliminary study was performed to assess the highest non-irritant dose and established to a dilution of test item at 5% in water, 0,25 mL

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 6 intradermal injections and 1 topical application
- Exposure period: 48 hours
- Test groups:
- 2 intradermal injections of FCA at 50% in NaCl
- 2 intradermal injections of 0.1 mL of test item diluted at 5% in water
- 2 intradermal injections of 0.1 mL of test item at the selected concentration formulated in a 1:1 mixture (v/v) FCA/ NaCl.
- Control group:
- 2 intradermal injections of FCA at 50% in NaCl
- 2 intradermal injections of 0.1 mL of water
- Site: shoulder
- Frequency of applications: d-0: intradermal injection, d-7: topical application
- Duration: 0-7 days

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: d-25
- Exposure period: 24 hours
- Test groups: 0.25 mL of test item diluted at 5% in water
- Control group: 0.25 mL of test item diluted at 5% in water
- Evaluation (hr after challenge): T+24 hours and T+48 hours

Positive control substance(s):
no

Results and discussion

Positive control results:
n/a

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0
No. with + reactions:
5
Total no. in group:
10
Reading:
2nd reading
Hours after challenge:
24
Group:
negative control
Dose level:
0
No. with + reactions:
0
Total no. in group:
10
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0.25 ml of product
No. with + reactions:
8
Total no. in group:
10
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
0.25 ml of product
No. with + reactions:
0
Total no. in group:
10
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
0
No. with + reactions:
0
Total no. in group:
0
Remarks on result:
other: No positive control
Reading:
2nd reading
Hours after challenge:
48
Group:
positive control
Dose level:
0
No. with + reactions:
0
Total no. in group:
0
Remarks on result:
other: No positive control

Any other information on results incl. tables

At 24 hours, 5/10 showed an erythema, 1/10 showed an edema and 1/10 showed an erythema/edema, all grade 1

At 48 hours, neither erythema nor edema was observed in any animals

When compared to negative controls, 10% of treated animals were considered to show sensitization.

Please see the illustration of the results below for more details.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Laurydone has been tested according to the Magnusson & Kligman method. 10% of animal exposed to the test item have showed a positive response, which correspond to a class I : sensitizing potential very small.
Under these conditions, the test item has a very low sensitizing potential.

According to the study following TG OECD 406 (1981), test item is not classified as skin sensitizer according to CLP regulation.
The study had no positive controls and only 10 treated animals (20 required if not classifying as sensitizer). However these deviations do not impact the reliability of the conclusion because the overall sensitivity stays adequate:
- the intradermal dose was above requirements (0.25 mL vs. 0.1 mL required; concentration 5%)
- some reaction was observed, proving the test system was reactive
- only 10% animals were sensitized, this is clearly below the classification cut-off in CLP (30% for intradermal concentration > 1%), doubling the number of animals is highly unlikely to lead to reach the 30% cut-off.